From a hormonal perspective, the incidence of bladder cancer was shown to be higher in postmenopausal than in premenopausal women 15, and aggressive bladder cancers expressed high levels of estrogen receptor-β and few androgen receptors 16–18. This evidence concerns the gene AR and urinary bladder cancer.